People: Bausch Health Companies Inc (BHC.TO)
25 Jun 2019
von Eschenbach, Andrew
Dr. Andrew C. von Eschenbach is Independent Director of the Company. Dr. von Eschenbach was appointed acting commissioner of the U.S. Food and Drug Administration in 2005, was later confirmed by the Senate as commissioner in 2006 and then held the role until his resignation in 2009. Prior to that, he served as director of the National Cancer Institute at the National Institutes of Health from 2002 to 2006. Dr. von Eschenbach also previously served as a physician, surgeon, oncologist and executive at the University of Texas MD Anderson Cancer Center from 1976 until 2002, and since 2009, he has continued to serve as an adjunct professor there. He also currently serves as president of Samaritan Health Initiative and as a senior fellow at the Milken Institute. Dr. von Eschenbach earned a B.S. from St. Joseph's University and a M.D. from Georgetown University. Following medical school, he served as a lieutenant commander in the U.S. Naval Medical Corps. He completed his residency at Pennsylvania Hospital in Philadelphia and served as an instructor in Urology at the University of Pennsylvania School of Medicine. He then completed a fellowship in Urologic Oncology at the University of Texas MD Anderson Cancer Center.
|Total Annual Compensation,||--|
|Restricted Stock Award,||--|
|Long-Term Incentive Plans,||--|
|Fiscal Year Total,||--|